-
1
-
-
77950525914
-
A transposon andtransposase system for human application
-
Hackett PB, Largaespada DA, Cooper LJ. A transposon andtransposase system for human application. Mol Ther. 2010;18:674-683
-
(2010)
Mol Ther
, vol.18
, pp. 674-683
-
-
Hackett, P.B.1
Largaespada, D.A.2
Cooper, L.J.3
-
2
-
-
33749536744
-
Transposons for gene therapy!
-
DOI 10.2174/156652306778520647
-
Ivics Z, Izsvak Z. Transposons for gene therapy! Curr GeneTher. 2006;6:593-607 (Pubitemid 44524462)
-
(2006)
Current Gene Therapy
, vol.6
, Issue.5
, pp. 593-607
-
-
Ivics, Z.1
Izsvak, Z.2
-
3
-
-
77950953208
-
PiggyBac transposon/transposase system to generate CD19-specific T cells for thetreatment of B-lineage malignancies
-
Manuri PV, Wilson MH, Maiti SN, et al. piggyBac transposon/transposase system to generate CD19-specific T cells for thetreatment of B-lineage malignancies. Hum Gene Ther. 2010;21:427-437
-
(2010)
Hum Gene Ther
, vol.21
, pp. 427-437
-
-
Manuri, P.V.1
Wilson, M.H.2
Maiti, S.N.3
-
4
-
-
69249221308
-
Efficient nonviral SleepingBeauty transposon-based TCR gene transfer to peripheral bloodlymphocytes confers antigen-specific antitumor reactivity
-
Peng PD, Cohen CJ, Yang S, et al. Efficient nonviral SleepingBeauty transposon-based TCR gene transfer to peripheral bloodlymphocytes confers antigen-specific antitumor reactivity. GeneTher. 2009;16:1042-1049
-
(2009)
GeneTher
, vol.16
, pp. 1042-1049
-
-
Peng, P.D.1
Cohen, C.J.2
Yang, S.3
-
5
-
-
84863337890
-
B-cell depletion and remissions of malignancy along withcytokine- associated toxicity in a clinical trial of anti-CD19chimeric-antigen-receptor- transduced T cells
-
Kochenderfer JN, Dudley ME, Feldman SA, et al.B-cell depletion and remissions of malignancy along withcytokine-associated toxicity in a clinical trial of anti-CD19chimeric-antigen-receptor-transduced T cells. Blood. 2012;119:2709-2720
-
(2012)
Blood
, vol.119
, pp. 2709-2720
-
-
Kochenderfer, J.N.1
Dudley, M.E.2
Feldman, S.A.3
-
6
-
-
78549278144
-
Eradicationof B-lineage cells and regression of lymphoma in a patienttreated with autologous T cells genetically engineered torecognize CD19
-
Kochenderfer JN, Wilson WH, Janik JE, et al. Eradicationof B-lineage cells and regression of lymphoma in a patienttreated with autologous T cells genetically engineered torecognize CD19. Blood. 2010;116:4099-4102
-
(2010)
Blood
, vol.116
, pp. 4099-4102
-
-
Kochenderfer, J.N.1
Wilson, W.H.2
Janik, J.E.3
-
7
-
-
80051720194
-
Chimeric antigenreceptor-modified T cells in chronic lymphoid leukemia
-
Porter DL, Levine BL, Kalos M, et al. Chimeric antigenreceptor-modified T cells in chronic lymphoid leukemia. N EnglJ Med. 2011;365:725-733
-
(2011)
N EnglJ Med
, vol.365
, pp. 725-733
-
-
Porter, D.L.1
Levine, B.L.2
Kalos, M.3
-
8
-
-
77956668327
-
Translating SleepingBeauty transposition into cellular therapies: Victories andchallenges
-
Izsvak Z, Hackett PB, Cooper LJ, et al. Translating SleepingBeauty transposition into cellular therapies: victories andchallenges. Bioessays. 2010;32:756-767
-
(2010)
Bioessays
, vol.32
, pp. 756-767
-
-
Izsvak, Z.1
Hackett, P.B.2
Cooper, L.J.3
-
9
-
-
80053997259
-
A human memory T cellsubset with stem cell-like properties
-
Gattinoni L, Lugli E, Ji Y, et al. A human memory T cellsubset with stem cell-like properties. Nat Med. 2011;17:1290-1297
-
(2011)
Nat Med
, vol.17
, pp. 1290-1297
-
-
Gattinoni, L.1
Lugli, E.2
Ji, Y.3
|